Hyderabad, May 12 () Dr Reddy's Laboratories Ltd on Wednesday announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of Invanz approved by the US Food and ...

A magnifying glass. It indicates, "Click to perform a search". A magnifying glass. It indicates, "Click to perform a search". DUBLIN, July 27, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP ...

Fresenius Kabi is introducing ertapenem for injection in a 1 gram vial presentation. The new product is the generic of Merck’s Invanz. Ertapenem for injection is indicated in adult patients and ...

FDA Approves New Indication for INVANZ (ertapenem) for the Prevention of Surgical Site Infections (SSI) following Elective Colorectal Surgery in Adults WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck ...

Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Ertapenem injection 1 g/vial. Aurobindo’s Ertapenem injection is a generic ...

The Invanz brand and generic had a market value of $205 million for the 12 months ended March 2021, according to IQVIA. Dr. Reddy’s is introducing ertapenem for injection, 1 g/vial. The product is the ...

DUBLIN, July 27, 2018 /CNW/ -- Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of ...

Dr Reddy's Laboratories Ltd on Wednesday announced the launch of Ertapenem for Injection, 1 g/vial, a therapeutic equivalent generic version of Invanz approved by the US Food and Drug Administration. ...